03/28/2025
4:01 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
7:00 AM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
4:29 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
3:15 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/17/2025
3:17 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
5:00 PM | Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
PROEHL GERALD T (Filed by)
| Form SCHEDULE 13D/A | |
02/05/2025
11:15 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form EFFECT | |
02/05/2025
4:30 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 424B3 | |
02/04/2025
3:22 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form D/A | |
01/30/2025
3:09 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for DRMA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/28/2025
4:25 PM | Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G | |
01/28/2025
4:00 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/23/2025
8:54 PM | Dermata Therapeutics (Subject)
Dermata Therapeutics, Inc. (Subject)
PROEHL GERALD T (Filed by)
| Form SCHEDULE 13D/A | |
01/23/2025
4:00 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
HALE DAVID F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:02 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
PROEHL GERALD T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:03 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Van Hoose Kyri K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
4:04 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
FISHER MARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:16 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
7:05 AM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
5:56 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
WIERENGA WENDELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:56 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
HALE DAVID F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:56 PM | Bedoya-Toro Munera Maria E (Reporting)
Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:57 PM | Bradrick Brittany (Reporting)
Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:57 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Nardo Christopher J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:58 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Sandler Andrew Seth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:49 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Scott Kathleen D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Mento Steven J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
PROEHL GERALD T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
Van Hoose Kyri K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
5:50 PM | Dermata Therapeutics (Issuer)
Dermata Therapeutics, Inc. (Issuer)
FISHER MARY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:16 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/27/2024
4:00 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/24/2024
11:15 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form EFFECT | |
09/24/2024
3:16 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 424B3 | |
09/19/2024
3:46 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/17/2024
4:25 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:49 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/14/2024
11:15 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form EFFECT | |
06/07/2024
4:09 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 424B5 | |
06/07/2024
4:11 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before April 23rd |
06/05/2024
8:02 AM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:06 PM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
8:00 AM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
8:16 AM | Dermata Therapeutics (Filer)
Dermata Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
